FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:222-223 January 18, 2001 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by de Quiros, J. C. L. B. Related Article by Ledergerber, B. PubMed Citation

Until the widespread adoption of specific prophylaxis in the late 1980s, Pneumocystis carinii pneumonia was among the most common life-threatening opportunistic infections associated with infection with the human immunodeficiency virus (HIV) in industrialized countries. Primary prophylaxis against P. carinii pneumonia is currently recommended for all HIV-infected patients with CD4 cell counts of less than 200 per cubic millimeter and for those receiving cytotoxic chemotherapy. Secondary prophylaxis is recommended for all patients with a history of P. carinii pneumonia.¹

The advent of highly active antiretroviral therapy, which can drastically inhibit HIV replication and lead to substantial increases in CD4 cell counts, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Atzori, C., Clerici, M., Trabattoni, D., Fantoni, G., Valerio, A., Tronconi, E., Cargnel, A. (2003). Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens. J Antimicrob Chemother 52: 276-281 [Abstract] [Full Text]  
• Bender, M. A., Sax, P. E., Le Moal, G., Breux, J.-P., Roblot, F., Lopez Bernaldo de Quiros, J. C., Miro, J. M., Pena, J. M., Lundgren, J., Reiss, P., Ledergerber, B. (2001). Discontinuing Prophylaxis against Pneumocystis carinii Pneumonia. NEJM 344: 1639-1641 [Full Text]  
• (2001). Secondary Pneumocystis carinii Prophylaxis Safely Stopped. JWatch Infect. Diseases 2001: 7-7 [Full Text]